World Library  
Flag as Inappropriate
Email this Article


Article Id: WHEBN0006149878
Reproduction Date:

Title: Phenoperidine  
Author: World Heritage Encyclopedia
Language: English
Subject: List of opioids, General anesthetics, Thiotetrabarbital, Dieticyclidine, Narcobarbital
Publisher: World Heritage Encyclopedia


Systematic (IUPAC) name
ethyl 1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-carboxylate
Clinical data
Legal status
Routes of
Pharmacokinetic data
Metabolism Liver
Excretion Bile and Urine
CAS Registry Number  N
ATC code N01
PubChem CID:
ChemSpider  YesY
Chemical data
Formula C23H29NO3
Molecular mass 367.481

Phenoperidine (Operidine or Lealgin), is an opioid used as a general anesthetic.

Medical use

Phenoperidine is an opioid pain killer -- narcotic analgesic.


It is a derivative of isonipecotic acid, like pethidine, and is metabolized in part to norpethidine. It is 20-200 times as potent as pethidine as an analgesic. The greatly increased potency essentially eliminates the toxic effects of norpethidine accumulation which are seen when pethidine is administered in high doses or for long periods of time.

History and Synthesis

Phenoperidine was first synthesized in 1957 by Paul Janssen, of the company now known as Janssen Pharmaceutica, who was seeking better opioid pain-killers.[1] His two prototype drugs were methadone and pethidine, each which had been invented in 1930s by Otto Eisleb, who worked for IG Farben. His initial work starting with methadone yielded dextromoramide in 1954. Janssen then turned to making pethidine analogues, due in part to the less complicated chemistry of the compound. During his explorations, he replaced the methyl group attached to the pethidine nitrogen with a propiophenone group, and this yielded phenoperidine, in 1957. Phenoperidine was determined to have decreased stability and enhanced lipophilicity compared to pethidine. Soon after, studies in mice showed that phenoperidine was over 100 times more potent than pethidine.[1]

In 1958, the same line of work yielded “one of the greatest advances of the 20th century psychiatry", haloperidol,[1] as well as diphenoxylate, which lacked the opioid's analgesic properties but still stopped peristalsis in the intestines, a typical side effect of opioids; Janssen brought diphenoxylate to market as a drug to treat diarrhea.[2]:124 And through further advances, Janssen created fentanyl in 1960, which proved to be ten times more potent than phenoperidine.[3]

Historical Uses

In 1959, the combination of phenoperidine and haloperidol was first used in Europe in anesthesia to induce a detached, pain free state called Neuroleptic analgesia; the use of that mixture boomed in early 1960s but was overtaken by the combination of fentanyl and droperidol, which was widely used through the 1980s. These combination approaches were not adopted in the US.[4]:644


In 1961 phenoperidine was added to the 1931 Single Convention on Narcotic Drugs.[5][6]

In the US it is classified as a schedule 1 opiate and is categorized as a Drug Enforcement Administration (DEA) controlled substance with a corresponding code 9641.[7]


  1. ^ a b c
  2. ^ Walter Sneade. Drug Discovery: A History. John Wiley & Sons, 2005 ISBN 9780471899792
  3. ^
  4. ^ Edmond I Eger II, Lawrence Saidman, Rod Westhorpe. The Wondrous Story of Anesthesia. Springer Science & Business Media, 2013 ISBN 9781461484417
  5. ^ WHO Technical Report Series No. 211. 1961 Expert Committee on Addiction-Producing Drugs. Eleventh Report.
  6. ^ WHO Executive Board. 17 April, 1961 Action in Respect of the International Convention on Narcotic Drugs.
  7. ^

External links

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.